ArticleCurrent oncology (Toronto, Ont.)2023

Active Pharmacovigilance Study: A Follow-Up Model of Oral Anti-Cancer Drugs under Additional Monitoring.

Sofia Pinto Carvalho da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.